STAT

Bill Nye takes the #STATBreakthrough East stage for a rare, personal conversation about ataxia — a neurological disease that has impacted his family for generations. Don’t miss this powerful discussion. Get your tickets: https://lnkd.in/gN4y3nGJ National Ataxia Foundation, Anil Oza

The companies reported Wednesday that batoclimab showed improvements in myasthenia gravis patients in a Phase 3 trial. https://trib.al/xqEbPE1

The cuts to U.S. foreign aid could result in the resurgence of some diseases. They've also forced health workers out of their jobs. https://trib.al/79pMzIZ

Finally, MASH's Moment The liver disease called MASH, linked to obesity, has been the next big thing in biotech for more than a decade. Now, new medicines are finally generating excitement for patients and investors alike. How an old disease became the new, new thing. With Carole Huntsman of Madrigal Pharmaceuticals, Kitty Yale of Akero Therapeutics, and STAT's Adam Feuerstein Virtual passes still available: https://lnkd.in/gN4y3nGJ

Cost isn’t the only barrier to a healthy diet. Taste is, too, writes Marc Siegel — and efforts to improve what America eats have to keep that in mind. https://trib.al/IDIucwK

In the time since the Novartis gene therapy Zolgensma was approved for babies with spinal muscular atrophy, other treatments have hit the market. https://trib.al/4O4Mkgh

The FDA has warned Aspen Pharmacare, the largest pharmaceutical company in Africa, over sterility issues at a key plant. https://trib.al/MiDmuKG

Prime Medicine and Beam Therapeutics had common origins in gene editing. Now they're both pursuing treatments for the same disease. https://trib.al/D7K0m7x

NEW with Sarah Todd: RFK Jr and other HHS leaders met with US infant formula companies today. They discussed infant formula supply, regulatory standards for European companies, and the rationale for including certain ingredients — particularly seed oils. https://lnkd.in/epVT2g7F

The longtime director of the National Human Genome Research Institute is stepping down, as the larger NIH braces for more changes. https://trib.al/sqo6aNR